IllnessEndometrium cancer [heritable, susceptibility]
Summary
Comprehensive differential diagnostic panel for Endometrium cancer (inherited, susceptibility) comprising 6 guideline-curated genes as well as another curated gene according to the clinical signs
- (Extended panel: incl. additional genes)
- EDTA-anticoagulated blood (3-5 ml)
NGS +
[Sanger]
Gene panel
Informations about the disease
Endometrial cancer can run in families. These families also have a higher risk for colon cancer, i.e. HNPCC (Lynch syndrome). In many cases, HNPCC is caused by a defect in mismatch repair genes MLH1, MSH2, MLH3, MSH6, TGBR2, PMS1, PMS2. Mutation(s) in any one of these genes reduces the ability to repair DNA damage. This results in a very high risk of cancer, especially also endometrial cancer. Women with this syndrome have a up to a 70% risk of developing endometrial cancer, while the risk for women in general is ~3%. The risk of ovarian cancer is also increased.
- Alias: Uterus-Karzinom
- Colorectal cancer, hereditary nonpolyposis, type 1 (MSH2)
- Colorectal cancer, hereditary nonpolyposis, type 2 (MLH1)
- Colorectal cancer, hereditary nonpolyposis, type 4 (PMS2)
- Colorectal cancer, hereditary nonpolyposis, type 5 (MSH6)
- Colorectal cancer, hereditary nonpolyposis, type 8 (EPCAM)
- Cowden syndrome 1 (PTEN)
- Diarrhea 5, with tufting enteropathy, congenital (EPCAM)
- Endometrial cancer, familial (MSH6)
- Endometrial carcinoma
- Fumarase deficiency (FH)
- Glioma susceptibility 2 (PTEN)
- Leiomyomatosis + renal cell cancer (FH)
- Lhermitte-Duclos syndrome (PTEN)
- Macrocephaly/autism syndrome (PTEN)
- Meningioma (PTEN)
- Mismatch repair cancer syndrome (MLH1, MSH2, MSH6, PMS2)
- Muir-Torre syndrome (MLH1, MSH2)
- Prostate cancer, somatic (PTEN)
- AD
- Sus
- n.k.
- Multiple OMIM-Ps
Bioinformatics and clinical interpretation
No text defined